We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A jury sided with Amgen Wednesday in a suit accusing Regeneron and Sanofi of violating two of its patents when they developed a cholesterol-fighting biologic. Read More